Status:
COMPLETED
Midazolam Additive to Local Anesthetic in Peribulbar Block
Lead Sponsor:
Al Jedaani Hospital
Conditions:
Postoperative Pain
Cataract
Eligibility:
All Genders
40-70 years
Phase:
NA
Brief Summary
Regional eye blocks are usually preferred for ophthalmic procedures. Peribulbar block (PBB) is a safe alternative for patients undergoing cataract surgery. Many studies tried to solve this issue by me...
Eligibility Criteria
Inclusion
- 90 adult patients with ASA physical status I to III
- Aged 40-70 years
- Scheduled for elective extracapsular or phacoemulsification cataract surgery with peribulbar block
- No history of allergy to local anesthetics
- Axial length less than 28 mm.
Exclusion
- Patient's refusal to share in the study
- communication barrier (e.g. impaired hearing, disturbed conscious level, impaired mental status)
- uncontrolled tremors
- morbidly obese patients
- allergy to lidocaine
- coagulation abnormalities
- glaucoma
- recent surgical procedure on the same eye.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2018
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03397069
Start Date
January 1 2018
End Date
May 1 2018
Last Update
August 14 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al Jedaani group of hospitals
Jeddah, Meccah, Saudi Arabia, 21462/7500